Please login to the form below
symptoms
This page shows the latest symptoms news and features for those working in and with pharma, biotech and healthcare.
GSK’s Ojjaara receives FDA approval to treat myelofibrosis patients with anaemia
The trial met all of its primary and key secondary endpoints, with Ojjaara-treated patients showing improved symptoms, spleen size and transfusion independent compared with patients receiving danazol.
Latest news
-
MJFF awards Nine Square Therapeutics $4.5m for Parkinson’s disease research
As a challenging condition to diagnose, varying symptoms and early signs of the condition such as tremors, stiffness and slowness, are primarily relied on in order to diagnose patients. ... However, symptoms often appear many years after the onset of PD.
-
Takeda announces positive phase 2b results for TAK-279 in psoriatic arthritis
The study met its primary endpoint, with a greater proportion of patients treated once-daily with TAK-279 achieving at least a 20% improvement in signs and symptoms of disease at
-
AbbVie shares positive results from head-to-head study of Skyrizi in Crohn's disease
Crohn’s disease is a chronic, progressive condition of the digestive system, causing symptoms such as persistent diarrhoea and abdominal pain.
-
ICR study supports use of new radioactive treatment for advanced prostate cancer
9.7 months for Lu-PSMA-dosed patients’ quality of life to worsen and 14.3 months for symptoms to worsen, compared to 2.4 months and 2.9 months for
-
NICE issues two recommendations for UCB's inflammatory disease drug
The approval was supported by results from two phase 3 trials in which Bimzelx showed improvements over placebo in joint and skin symptoms across biologic naïve and TNF inhibitor-inadequate responder ... symptoms and disease activity across the full
More from news
Approximately 3 fully matching, plus 1,593 partially matching documents found.
Latest Intelligence
-
Vive la différence: as Cannes celebrates life-changing creative, how did pharma do?
Using the tool exercises the muscles in the face, helping delay symptoms of muscle atrophy.
-
Powering creativity to work in harmony with science and data
them recognise symptoms and diagnose the condition early.
-
Can the patient pathway provide a route to success?
Essentially, a patient pathway is the journey of patients through a healthcare system, usually within a specific disease area, from people’s recognition of symptoms, leading to their first contact with ... Because administration of innovative SMA
-
Parkinson’s disease: past, present and future
such as levodopa and COMT inhibitors, that can help manage the symptoms of the disease. ... convenient and tolerable agents to manage the symptoms of Parkinson’s disease is an unmet need that can hopefully be answered.
-
The 17th World Congress on Controversies in Neurology
They explained how their initial symptoms, often blurred vision, were ignored and misdiagnosed, and how they struggled with uncertainty before getting a diagnosis and treatment. ... It has been a good opportunity and it can lead to positive benefits and
More from intelligence
Approximately 0 fully matching, plus 164 partially matching documents found.
Latest appointments
-
Srdjan Stankovic joins Acadia Pharmaceuticals
Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.
-
Bayer's Kirstyn Nicholas joins Spirit Healthcare
Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.
-
Ex-Bayer R&D chief joins Gemmus Pharma board
San Francisco-based Gemmus was founded in 2007 and is developing a drug that decreases the severity of flu symptoms by modulating the release of pro-inflammatory cytokines.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Porphyria Awareness Week – Round Up
Symptoms are broad and can vary dramatically in severity, often leaving doctors mystified whilst patients suffer.
-
Breaking the silence: It’s time to talk about the menopause
Furthermore, 69% agreed there should be more treatments available for the symptoms of menopause. ... symptoms of menopause, and how she and her family come to accept it.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
2) The child may display a variety of different symptoms which do not match one disorder and a clear diagnosis is not reached. ... 3) The child might have an array of symptoms that are in fact an unusual presentation of a known rare condition.
-
Could femtech be the answer to the gender health gap?
Users are first asked to input dates of their menstrual periods along with information on their symptoms. ... on the subject – giving women access to someone who they know will take their symptoms seriously.
-
Navigating the nocebo effect through patient engagement is the key to setting patients up for success
The nocebo effect is described as a phenomenon “causing patients to develop side effects or unwanted symptoms, or reject treatment, due to the belief that the medical intervention will cause harm.”
More from PMHub
Approximately 0 fully matching, plus 186 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
Genesis Research
Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
